Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA versus placebo for intrahepatic cholestasis of pregnancy
ISRCTN91918806Phase 3Completed
- Sponsor
- King's College London
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in intrahepatic cholestasis of pregnancy (ICP) comparing Ursofalk with Placebo (2 arms). Primary endpoint: Composite perinatal outcome. Started Oct 2015; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
intrahepatic cholestasis of pregnancy (ICP)
Beyond the preview
Go deeper on ISRCTN91918806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91918806.